419 related articles for article (PubMed ID: 19114908)
1. Tight glycemic control may favor fibrinolysis in patients with sepsis.
Savioli M; Cugno M; Polli F; Taccone P; Bellani G; Spanu P; Pesenti A; Iapichino G; Gattinoni L
Crit Care Med; 2009 Feb; 37(2):424-31. PubMed ID: 19114908
[TBL] [Abstract][Full Text] [Related]
2. Activation of the fibrinolytic system and utilization of the coagulation inhibitors in sepsis: comparison with severe sepsis and septic shock.
Mavrommatis AC; Theodoridis T; Economou M; Kotanidou A; El Ali M; Christopoulou-Kokkinou V; Zakynthinos SG
Intensive Care Med; 2001 Dec; 27(12):1853-9. PubMed ID: 11797019
[TBL] [Abstract][Full Text] [Related]
3. Early inhibition of activated fibrinolysis predicts microbial infection, shock and mortality in febrile medical patients.
Raaphorst J; Johan Groeneveld AB; Bossink AW; Erik Hack C
Thromb Haemost; 2001 Aug; 86(2):543-9. PubMed ID: 11522001
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of an intensive insulin protocol for septic patients in a medical intensive care unit.
Clayton SB; Mazur JE; Condren S; Hermayer KL; Strange C
Crit Care Med; 2006 Dec; 34(12):2974-8. PubMed ID: 17075371
[TBL] [Abstract][Full Text] [Related]
5. TAFI and PAI-1 levels in human sepsis.
Zeerleder S; Schroeder V; Hack CE; Kohler HP; Wuillemin WA
Thromb Res; 2006; 118(2):205-12. PubMed ID: 16009400
[TBL] [Abstract][Full Text] [Related]
6. Effects of recombinant human activated protein C on the fibrinolytic system of patients undergoing conventional or tight glycemic control.
Polli F; Savioli M; Cugno M; Taccone P; Bellani G; Spanu P; Pesenti A; Iapichino G; Gattinoni L
Minerva Anestesiol; 2009; 75(7-8):417-26. PubMed ID: 19002087
[TBL] [Abstract][Full Text] [Related]
7. Impact of tight glycemic control on cerebral glucose metabolism after severe brain injury: a microdialysis study.
Oddo M; Schmidt JM; Carrera E; Badjatia N; Connolly ES; Presciutti M; Ostapkovich ND; Levine JM; Le Roux P; Mayer SA
Crit Care Med; 2008 Dec; 36(12):3233-8. PubMed ID: 18936695
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of fibrinolysis in poorly controlled, hospitalized type 2 diabetic patients by short-term metabolic control: association with a decrease in plasminogen activator inhibitor 1.
Aso Y; Okumura KI; Yoshida N; Tayama K; Takemura Y; Inukai T
Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):175-80. PubMed ID: 15127320
[TBL] [Abstract][Full Text] [Related]
9. Pronounced elevation of resistin correlates with severity of disease in severe sepsis and septic shock.
Sundén-Cullberg J; Nyström T; Lee ML; Mullins GE; Tokics L; Andersson J; Norrby-Teglund A; Treutiger CJ
Crit Care Med; 2007 Jun; 35(6):1536-42. PubMed ID: 17452927
[TBL] [Abstract][Full Text] [Related]
10. Increase of plasminogen activator inhibitor levels predicts outcome of leukocytopenic patients with sepsis.
Mesters RM; Flörke N; Ostermann H; Kienast J
Thromb Haemost; 1996 Jun; 75(6):902-7. PubMed ID: 8822584
[TBL] [Abstract][Full Text] [Related]
11. The vasopressin and copeptin response to infection, severe sepsis, and septic shock.
Jochberger S; Dörler J; Luckner G; Mayr VD; Wenzel V; Ulmer H; Morgenthaler NG; Hasibeder WR; Dünser MW
Crit Care Med; 2009 Feb; 37(2):476-82. PubMed ID: 19114902
[TBL] [Abstract][Full Text] [Related]
12. [Fibrinolysis system in patients with sepsis in state of myelotoxic agranulocytosis].
Galstian GM; Krechetova AV; Vasil'ev SA; Orel EB; Pustovoĭt LA; Egorova EO; Saridi EIu; Gemdzhian EG; Gorodetskiĭ VM
Anesteziol Reanimatol; 2012; (2):41-8. PubMed ID: 22834287
[TBL] [Abstract][Full Text] [Related]
13. Plasmapheresis in severe sepsis and septic shock: a prospective, randomised, controlled trial.
Busund R; Koukline V; Utrobin U; Nedashkovsky E
Intensive Care Med; 2002 Oct; 28(10):1434-9. PubMed ID: 12373468
[TBL] [Abstract][Full Text] [Related]
14. Elevated serum levels of S-100beta protein and neuron-specific enolase are associated with brain injury in patients with severe sepsis and septic shock.
Nguyen DN; Spapen H; Su F; Schiettecatte J; Shi L; Hachimi-Idrissi S; Huyghens L
Crit Care Med; 2006 Jul; 34(7):1967-74. PubMed ID: 16607230
[TBL] [Abstract][Full Text] [Related]
15. Intensive insulin therapy confers a similar survival benefit in the burn intensive care unit to the surgical intensive care unit.
Gibson BR; Galiatsatos P; Rabiee A; Eaton L; Abu-Hamdah R; Christmas C; Milner SM; Andersen DK; Elahi D
Surgery; 2009 Nov; 146(5):922-30. PubMed ID: 19733884
[TBL] [Abstract][Full Text] [Related]
16. Practice and perception--a nationwide survey of therapy habits in sepsis.
Brunkhorst FM; Engel C; Ragaller M; Welte T; Rossaint R; Gerlach H; Mayer K; John S; Stuber F; Weiler N; Oppert M; Moerer O; Bogatsch H; Reinhart K; Loeffler M; Hartog C;
Crit Care Med; 2008 Oct; 36(10):2719-25. PubMed ID: 18766100
[TBL] [Abstract][Full Text] [Related]
17. Diabetes does not alter mortality or hemostatic and inflammatory responses in patients with severe sepsis.
Stegenga ME; Vincent JL; Vail GM; Xie J; Haney DJ; Williams MD; Bernard GR; van der Poll T
Crit Care Med; 2010 Feb; 38(2):539-45. PubMed ID: 19851093
[TBL] [Abstract][Full Text] [Related]
18. The impact of the severity of sepsis on the risk of hypoglycaemia and glycaemic variability.
Waeschle RM; Moerer O; Hilgers R; Herrmann P; Neumann P; Quintel M
Crit Care; 2008; 12(5):R129. PubMed ID: 18939991
[TBL] [Abstract][Full Text] [Related]
19. How does blood glucose control with metformin influence intensive insulin protocols? Evidence for involvement of oxidative stress and inflammatory cytokines.
Ansari G; Mojtahedzadeh M; Kajbaf F; Najafi A; Khajavi MR; Khalili H; Rouini MR; Ahmadi H; Abdollahi M
Adv Ther; 2008 Jul; 25(7):681-702. PubMed ID: 18636232
[TBL] [Abstract][Full Text] [Related]
20. [Early changes in function of hypothalamic-pituitary-target gland axis in patients with severe sepsis and septic shock].
Cui N; Liu DW; Wang H; Zeng ZP; Long Y; Chai WZ; Liu HZ; Wang XT
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Jun; 19(6):332-5. PubMed ID: 17577436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
